I-Mab Biopharma and ABL Bio Announce Global Collaboration on Innovative Bispecific Antibodies
SHANGHAI, July 26, 2018 /PRNewswire/ — I-Mab Biopharma (“I-Mab”), a company focusing on innovative biologics in immuno-oncology and immuno-inflammation, and ABL Bio Corporation (“ABL Bio”), a South Korean biotechnology company,…